Alicia Gerke MD
Critical Care Medicine, Pleural Disease
Pulmonary and Critical Care at University of Iowa
Join to view full profile
200 Hawkins DrIowa City, IA 52242
Phone+1 319-356-1616
Fax+1 319-353-6406
Dr. Gerke is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Iowa Health Care Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008- University of Iowa Health Care Medical CenterResidency, Internal Medicine, 2004 - 2005
Duke University HospitalResidency, Internal Medicine, 2002 - 2004
University of South Florida College of MedicineClass of 2002
Certifications & Licensure
IA State Medical License 2004 - 2027
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- The Diagnostic Course of Sarcoidosis: A Population-Based Study Highlighting Risk Factors for a Delay in Diagnosis.Miles D Hagner, Aaron Miller, Solanus De la Serna, Alan Arakkal, Joseph Cavanaugh
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2026-06-22 - 6 citationsA paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americ...Athol U Wells, Elyse E Lower, Robert P Baughman, Daniel A Culver, Marc A Judson
The Lancet. Respiratory Medicine. 2026-04-01 - Residential fungal β-(1,3)-D-glucan exposure is associated with decreased pulmonary function in fibrotic pulmonary sarcoidosis.Emma M Stapleton, Nervana Metwali, Michael Shlossman, Linder Wendt, Alejandro A Pezzulo
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2025-09-30
Grant Support
- The Role of Residential Bioaerosol Exposure in Pulmonary SarcoidosisUNIVERSITY OF IOWA2026–2031
- The Role of Residential Bioaerosol Exposure in Pulmonary SarcoidosisUNIVERSITY OF IOWA2024–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: